Diadema Partners »

Elicio Therapeutics shares owned by Diadema Partners

Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Elicio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Elicio Therapeutics held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elicio Therapeutics by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $829k 212k 3.91

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Elicio Therapeutics

Knoll Capital Management
BlackRock
Caption Management
Vanguard Capital Management
Ikarian Capital
Geode Capital Management
Susquehanna International
Diadema Partners
Toronto-Dominion Bank
Jane Street
Citadel Advisors
Northern Trust
Boothbay Fund Management
Vanguard Portfolio Management
Vanguard Fiduciary Trust

View all funds holding Elicio Therapeutics